Grandomics Biosciences
Business Services · 51-200 Employees
View Company Info for Free
Overview
Phone Number
+86 4006516230Website
www.grandomics.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Grandomics Biosciences
GrandOmics is a pioneer in third-generation sequencing technology and applications, established in 2011. The company focuses on technology development and application expansion in the fields of scientific services, medical diagnostics, bioinformatics, and advanced manufacturing. With over 5,000 square meters of research service platforms in Beijing and Wuhan, GrandOmics offers a range of services including genome sequencing, transcriptomics, and pathogen detection. The core team consists of experienced experts in third-generation sequencing, and the company has received multiple recognitions and investments, establishing itself as a leading brand in China.Explore more
Grandomics Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Grandomics Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Grandomics Biosciences launches new products
Check out if Grandomics Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Grandomics Biosciences has new funding data
Check if Grandomics Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Grandomics Biosciences
Website visits: Recent activity has been detected on your website
Click to see if Grandomics Biosciences had a recent Job posting/layoffs
Grandomics Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Grandomics Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Grandomics Biosciences as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Grandomics Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Grandomics Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Grandomics Biosciences.
Grandomics Biosciences financials insights
Gather financial insights about Grandomics Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$14M
Grandomics Biosciences Tech Stack
A closer look at the technologies used by Grandomics Biosciences
See more technologies
Grandomics Biosciences News & Media
UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China
SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis and GrandOmics, China's first third-generation sequencing service provider and the first third-generation sequencing based precision medicine company, announced at the 2018 annual meeting of the American Society of Human Genetics in San DiegoGrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China
SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis and GrandOmics, China's first third-generation sequencing service provider and the first third-generation sequencing based precision medicine company, announced at the 2018 annual meeting of the American Society of Human Genetics in San Diego
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Grandomics Biosciences
Sign Up For FreeTo access detailed company insights
GrandOmics is a pioneer in third-generation sequencing technology and applications, established in 2011. The company focuses on technology development and application expansion in the fields of scientific services, medical diagnostics, bioinformatics, and advanced manufacturing. With over 5,000 square meters of research service platforms in Beijing... Read More
